Concepedia

Jeremy G. Richman

JG

Statistics

Publications

22

Citations

1.9K

H-Index

20

Active since

1985

Affiliations

Arena Pharmaceuticals (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Arizona

Vanderbilt University Medical Center

Boehringer Ingelheim (United States)

Jeremy G. Richman is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, molecular pharmacology, and ligand binding.

Publications per year

1985–2017

22

Publications

22

(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G

Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan et al. · Journal of Biological Chemistry · 2005 · 651 citations · Full text

, , +17

Langerhans Cells Release Prostaglandin D2 in Response to Nicotinic Acid

Dominique Maciejewski-Lenoir, Jeremy G. Richman, Yaron Hakak et al. · Journal of Investigative Dermatology · 2006 · 190 citations · Full text

, , +11

Agonist-regulated Interaction between α2-Adrenergic Receptors and Spinophilin

Jeremy G. Richman, Ashley E. Brady, Qin Wang et al. · Journal of Biological Chemistry · 2001 · 123 citations · Full text

, , +17

Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors

Jeremy G. Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov et al. · Journal of Biological Chemistry · 2007 · 99 citations · Full text

, , +17

3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2008 · 96 citations · Full text

, , +14

1–5 of 22